{
    "code": "02021468",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021468",
    "time": "2020-02-25 12:42:26",
    "許可證字號": "衛署藥輸字第021468號",
    "註銷狀態": "已註銷",
    "註銷日期": "96\/05\/08",
    "註銷理由": "自請註銷",
    "有效日期": "95\/12\/12",
    "發證日期": "85\/12\/12",
    "許可證種類": "原料藥",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202146808",
    "中文品名": "鹽酸雷尼替定",
    "英文品名": "RANITIDINE HYDROCHLORIDE",
    "適應症": "Ｈ２接受體抗劑",
    "劑型": "043原料藥結晶性粉末",
    "包裝": "０．５公斤以上",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "01製劑原料",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1203701100  裕元興業股份有限公司",
        "申請商地址": "台北巿松江路１２９號９樓",
        "主製造廠": ""
    },
    "CCC號列": "29321920004 鹽酸雷尼得定（雷尼替定）Ranitidine HCL (N-[2[[[5-[( Dimethylamino )methyl]-2-furanyl] methyl]thio]ethyl]N’-methyl-2-nitro-1,1- ethenediamine hydrochloride",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "5640001210",
            "成分名稱": "RANITIDINE HCL",
            "含量描述": "97.5-102.0",
            "含量": "",
            "單位": "%"
        }
    ]
}